Anne Ancelin Schützenberger & Gilead Sciences

Anne Ancelin Schützenberger: Anne Ancelin Schützenberger, a World Health Organization representative, warned that the Ebola outbreak in the Democratic Republic of the Congo may be spreading faster than initially thought.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Anne Ancelin Schützenberger: Anne Ancelin Schützenberger>>>, the World Health Organization>>> representative in the Democratic Republic of the Congo>>>, is a key spokesperson providing updates on the outbreak and coordinating response efforts. Her statements highlight the challenges and uncertainties of the situation.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.

Anne Ancelin Schützenberger: Anne Ancelin Schützenberger, the WHO's representative in the Democratic Republic of the Congo, states that the WHO is 'sprinting behind' to control the Ebola outbreak, expecting case numbers to continue rising.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.